Determination of the ligand-binding specificities of the α2β1 and α1β1 integrins in a novel 3-dimensional in vitro model of pancreatic cancer

Pancreas

Volumn 34, Issue 2, 2007, Pages 220-228

  Grzesiak, John J ^a   Bouvet, Michael ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

3 dimensional in vitro model; Desmoplasia; Extracellular matrix; Integrins; Type I collagen

Indexed keywords

COLLAGEN RECEPTOR; COLLAGEN TYPE 1; COLLAGEN TYPE 4 RECEPTOR; GLYCOSAMINOGLYCAN; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 1; VERY LATE ACTIVATION ANTIGEN 2;

AFFINITY CHROMATOGRAPHY; ANTIGEN BINDING; ARTICLE; BINDING KINETICS; CANCER CELL CULTURE; CANCER MODEL; CELL ADHESION; CELL ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIGAND BINDING; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL;

ADENOCARCINOMA; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL DIVISION; CELL LINE, TUMOR; COLLAGEN TYPE I; COLLAGEN TYPE IV; CULTURE MEDIA, SERUM-FREE; GLYCOSAMINOGLYCANS; HUMANS; INTEGRIN ALPHA1BETA1; INTEGRIN ALPHA2BETA1; LIGANDS; PANCREATIC NEOPLASMS; PROTEIN BINDING;

EID: 33847152157     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpa.0000250129.64650.f6     Document Type: Article

References (51)

1. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer. 2002;2:897-909.
2. Bachem MG, Schunemann M, Ramadani M, et al. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology. 2005;128:907-921.
3. Armstrong T, Packham G, Murphy LB, et al. Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma. Clin Cancer Res. 2004;10:7427-7437.
4. Lohr M, Schmidt C, Ringel J, et al. Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Res. 2001;61:550-555.
5. Menke A, Adler G. TGFbeta-induced fibrogenesis of the pancreas. Int J Gastrointest Cancer. 2002;31:41-46.
6. Iacobuzio-Donahue CA, Ashfaq R, Maitra A, et al. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res. 2003;63:8614-8622.
7. Grzesiak JJ, Bouvet M. The alpha2beta1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines. Br J Cancer. 2006;94:1311-1319.
8. Schmeichel KL, Bissell MJ. Modeling tissue-specific signaling and organ function in three dimensions. J Cell Sci. 2003;116:2377-2388.
9. Kenny PA, Bissell MJ. Tumor reversion: correction of malignant behavior by microenvironmental cues. Int J Cancer. 2003;107:688-695.
10. Liu H, Radisky DC, Wang F, et al. Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J Cell Biol. 2004;164:603-612.
11. Theocharis AD, Tsara ME, Papageorgacopoulou N, et al. Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition. Biochim Biophys Acta. 2000;1502:201-206.
12. Masuda H, Ozeki T, Takazono I, et al. Composition of glycosaminoglycans in human pancreatic cancer. Biochem Med Metabol Biol. 1989;41:193-200.
13. Grzesiak JJ, Pierschbacher MD, Amodeo MF, et al. Enhancement of cell interactions with collagen/glycosaminoglycan matrices by RGD derivatization. Biomaterials. 1997;18:1625-1632.
14. Vezeridis MP, Meitner PA, Tibbetts LM, et al. Heterogeneity of potential for hematogenous metastasis in a human pancreatic carcinoma. J Surg Res. 1990;48:51-55.
15. Wayner EA, Carter WG. Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits. J Cell Biol. 1987;105:1873-1884.
16. Wayner EA, Carter WG, Piotrowicz RS, et al. The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J Cell Biol. 1988;107:1881-1891.
17. Wayner EA, Gil SG, Murphy GF, et al. Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for alpha 3 beta 1 positive T lymphocytes. J Cell Biol. 1993;121:1141-1152.
18. Fabbri M, Castellani P, Gotwals PJ, et al. A functional monoclonal antibody recognizing the human alpha 1-integrin I-domain. Tissue Antigens. 1996;48:47-51.
19. Cheresh DA, Spiro RC. Biosynthetic and functional properties of an Arg-Gly-AspYdirected receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor. J Biol Chem. 1987;262:17703-17711.
20. Sonnenberg A, Modderman PW, Hogervorst F. Laminin receptor on platelets is the integrin VLA-6. Nature. 1988;336:487-489.
21. Grzesiak JJ, Smith KC, Burton DW, et al. GSK3 and PKB/Akt are associated with integrin-mediated regulation of PTHrP, IL-6 and IL-8 expression in FG pancreatic cancer cells. Int J Cancer. 2005;114:522-530.
22. Grzesiak JJ, Davis GE, Kirchhofer D, et al. Regulation of alpha 2 beta 1-mediated fibroblast migration on type I collagen by shifts in the concentrations of extracellular Mg2+ and Ca2+. J Cell Biol. 1992;117:1109-1117.
23. Dagalakis N, Flink J, Stasikelis P, et al. Design of an artificial skin. III Part, Control of pore structure. J Biomed Mater Res. 1980;14:511-528.
24. Yannas IV, Burke JF. Design of an artificial skin. I. Basic design principles. J Biomed Mater Res. 1980;14:65-81.
25. Yannas IV, Burke JF, Gordon PL, et al. Design of an artificial skin. II Control of chemical composition. J Biomed Mater Res. 1980;14:107-132.
26. Yannas IV, Lee E, Orgill DP, et al. Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. Proc Natl Acad Sci U S A. 1989;86:933-937.
27. Grzesiak JJ, Smith KC, Chalberg C, et al. Heat shock protein-70 expressed on the surface of cancer cells binds parathyroid hormone-related protein in vitro. Endocrinology. 2005;146:3567-3576.
28. Grzesiak JJ, Clopton P, Chalberg C, et al. The extracellular matrix differentially regulates the expression of PTHrP and the PTH/PTHrP receptor in FG pancreatic cancer cells. Pancreas. 2004;29:85-92.
29. Grzesiak JJ, Smith KC, Chalberg C, et al. Type I collagen and divalent cation shifts disrupt cell-cell adhesion, increase migration, and decrease PTHrP, IL-6, and IL-8 expression in pancreatic cancer cells. Int J Gastrointest Cancer. 2005;36:131-146.
30. Linder S, Castanos-Velez E, von Rosen A, et al. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma. Hepatogastroenterology. 2001;48:1321-1327.
31. Lohr M, Trautmann B, Gottler M, et al. Expression and function of receptors for extracellular matrix proteins in human ductal adenocarcinomas of the pancreas. Pancreas. 1996;12:248-259.
32. Lohr M, Trautmann B, Gottler M, et al. Human ductal adenocarcinomas of the pancreas express extracellular matrix proteins. Br J Cancer. 1994;69:144-151.
33. Mollenhauer J, Roether I, Kern HF. Distribution of extracellular matrix proteins in pancreatic ductal adenocarcinoma and its influence on tumor cell proliferation in vitro. Pancreas. 1987;2:14-24.
34. Tempia-Caliera AA, Horvath LZ, Zimmermann A, et al. Adhesion molecules in human pancreatic cancer. J Surg Oncol. 2002;79:93-100.
35. White DJ, Puranen S, Johnson MS, et al. The collagen receptor subfamily of the integrins. Int J Biochem Cell Biol. 2004;36:1405-1410.
36. Kirchhofer D, Grzesiak J, Pierschbacher MD. Calcium as a potential physiological regulator of integrin-mediated cell adhesion. J Biol Chem. 1991;266:4471-4477.
37. Grzesiak JJ, Pierschbacher MD. Changes in the concentrations of extracellular Mg+ and Ca+ down-regulate E-cadherin and up-regulate alpha 2 beta 1 integrin function, activating keratinocyte migration on type I collagen. J Invest Dermatol. 1995;104:768-774.
38. Grzesiak JJ, Pierschbacher MD. Shifts in the concentrations of magnesium and calcium in early porcine and rat wound fluids activate the cell migratory response. J Clin Invest. 1995;95:227-233.
39. Sawai H, Yamamoto M, Okada Y, et al. Alteration of integrins by interleukin-1alpha in human pancreatic cancer cells. Pancreas. 2001;23:399-405.
40. Shimoyama S, Gansauge F, Gansauge S, et al. Altered expression of extracellular matrix molecules and their receptors in chronic pancreatitis and pancreatic adenocarcinoma in comparison with normal pancreas. Int J Pancreatol. 1995;18:227-234.
41. Monti P, Marchesi F, Reni M, et al. A comprehensive in vitro characterization of pancreatic ductal carcinoma cell line biological behavior and its correlation with the structural and genetic profile. Virchows Arch. 2004;445:236-247.
42. Peng B, Fleming JB, Breslin T, et al. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells. Clin Cancer Res. 2002;8:3628-3638.
43. Sipos B, Moser S, Kalthoff H, et al. A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch. 2003;442:444-452.
44. Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285:1028-1032.
45. Cukierman E, Pankov R, Yamada KM. Cell interactions with three-dimensional matrices. Curr Opin Cell Biol. 2002;14:633-639.
46. Miura K, Uniyal S, Leabu M, et al. Chemokine receptor CXCR4-beta1 integrin axis mediates tumorigenesis of osteosarcoma HOS cells. Biochem Cell Biol. 2005;83:36-48.
47. Weaver VM, Petersen OW, Wang F, et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol. 1997;137:231-245.
48. Nishimura S, Chung YS, Yashiro M, et al. Role of alpha 2 beta 1-and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma. Br J Cancer. 1996;74:1406-1412.
49. Bouvet M, Wang J, Nardin SR, et al. Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res. 2002;62:1534-1540.
50. Katz MH, Takimoto S, Spivack D, et al. A novel red fluorescent protein orthotopic pancreatic cancer model for the preclinical evaluation of chemotherapeutics. J Surg Res. 2003;113:151-160.
51. Katz MH, Takimoto S, Spivack D, et al. An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer. Clin Exp Metastasis. 2004;21:7-12.